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ABSTRACT
In the previous papers' J.:!), we investigated the effects of ACE inhibitory activities
of phosphopeptides of P-l and C-2 which were obtained from edible oyster by proteolytic
hydrolyzation.
In this investigation, the ACE inhibitory phosphopeptides of T-1 was further puri-
fied by ultrafiltration and Sephadex G-15 column chromatography.
ACE inhibitory activity was fractionated into three major phosphopeptides fractions
of T-1-1, T-1-2 and T-1-3 in the pepsin hydrolyzates of the T-1 by gel filtration
rechromatography on Sephadex G-15. The inhibition of ACE of the three kinds of
phosphopeptides fractions (T-l-l, T-1-2 and T-1-3) was analyzed in vitro.
The IC50 values of T-1-1, T-1-2 and T-1-3 of phosphopeptides for ACE were 0.159,
0.095 and 0.140 mg protein/ml, respectively. The T-1-2 fraction had the most potent
inyhibitory activity and showed 0.095 mg protein/ml inhibition against ACE at IC50
value.
It has been demonstrated that the T-1-1, T-1-2 and T-1-3 contained about 33.3%,
3.01 % and 27.12% as phosphonate-phosphorus of total phosphorus.
The amino acid compositions of the phosphopeptides fractions (T-1-1, T-1-2 and T-1-
3) were characterized by relatively high percentage for Tyr, Ser, Arg, Ala, Asp and Phe.
When the ACE inhibitory phosphopeptides were analyzed by thin layer chromatog-
raphy, some ninhydrine-positive spots were observed. These results suggest that the
phosphopeptides are a mixture of several phosphopeptides.
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INTRODUCTION
Our interest has been focused on the perparation and isolation of phosphopeptides
from natural resources that are involved in blood pressure regulation.
Many investigators have tried to prepare and insolate the ACD inhibitory pep-
tidel3 -121.
To date, there are still no reports on the ACE inhibitory activity of phosphoproteins
and phosphopeptides in nature.
In the previous papers l!,2,13-151, we have investigated that the inhibitory activities of
angiotensin 1-converting enzyme of phosphoproteins and phosphopeptides obtained
from proteolytic hydrolyzates of edible shellfishes.
In the previous paper! 11, we reported that the inhibitory activities of ACE detected
from digests by proteolytic enzymes such as pepsin, trypsin and chymotrypsin of oyster
extracts were fractionated into two major factions of high molecular weight and low
molecular weight by gel filtration chromatography on Sephadex G-50.
The ACE inhibitors were detected two major phosphoperptides of P-1 and P-2 in
pepsin digests, T-1 and T-2 in trypsin digests, C-1 and C-2 in chymotrypsin digests by
Sephadex G-50 column chromatography.
The P-1 had the most potent inhibitory activity and showed 0.30 mg protein/ml in-
hibition against ACE at IC50 value, and C-2, T-1 showed 1.47 and 2.73 mg protein/ml in-
hibition against ACE at IC50value, respectively.
In the previous paper I 2), we have also reported that the ACE inhibitory phospho-
peptides of P-1 and C-2 were further purified by ultrafiltration and Sephadex G-15 col-
umn chromatography. ACE inhibitory activity was fractionated into three major
phosphopeptides fractions of P-1-1, P-1-2 and P-1-3 in the pepsin hydrolyzates of the P-1,
and into fractions of C-2-1, C-2-2 and C-2-3 in the pepsin hydrolyzates of the C-2 by gel
filtration rechromatography on Sephadex G-15, respectively.
The P-1-2 fraction had the most potent inhibitory activity and showed 0.04 mg pro-
tein/ml inhibition against ACE at IC50 value.
When the ACE inhibitory phosphopeptides (P-1, P-2) were analyzed by TLC, some
ninhydrine-positive spots were observed. These results suggested that the phospho-
peptides were a mixture of several phosphopeptides.
In this investigation, therefore, T-1 of ACE inhibitors were further purified by
ultrafiltration, Sephadex G-15 column chromatography and thin layer chromatography
(TLC) .
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MATERIALS AND METHODS
Materials:
Sephadex G-15 was a product of Pharmacia. Proteolytic enzymes (pepsin, trypsin,
chymotrypsin) were obtained from Boehringerr Co. ACE from rabbit lung acetone
powder was obtained from Sigma Chemical Co. (U.S.A).
Hippuryl-L-histidyl-leucine (HHL) as a substrate was obtained from the Peptide
Institute (Osaka, Japan). All other reagents were obtained from Nacalai Tesque
(Kyoto, Japan).
Assay of ACE inhibitory activity:
The activity of ACE inhibition was assayed by the method of Yamamoto et.al'lI;.
For each assay, 100 III of AGE inhibitor and 50 III of Hip-His-Leu (2.5 mM in a borate
buffer containing 200 mM NaCl at pH 8.3) were incubated with 100 f.ll of 2.5 mu/ml of
ACE at 3TC for 30 min. The reaction was stopped by adding 250 f.ll of 1 M HC1, and 1.5
ml of ethyl acetate was thenn added to the mixture, and the mixture was shaked for 30
sec. The mixture was centrifuged at 2500 rpm for 10 min., and 1.25 ml from the super-
natant was transfered to test tube, and then heated at 120°C for 45 min., 0.5 ml of 1 M
NaCl was then added to the dried material, and the solution was shaked for 30 sec., and
the absorbance of the yielded hippuric acid at 228 nm was measured with a Hitachi 101
spectrophotometer. The ACE inhibitor concentration required to inhibit 50% of the
ACE activity is defined as the IG10 value.
Preparation and purification of ACE inhibitors from pepsin hydrolyzate:
The freeze-dried powder about 160 mg of T-1 obtained by Sephadex G-50 column
chromatography were dissolved in 10 ml of HCl buffer (pH 2.0), and then 10 mg of pep-
sin was added to the mixture, and the mixture incubated at 37°C for 24 hrs. After pro-
teolysis, the incubation mixture was adjusted with 0.1 N NaOH to pH 8.4, the solution
was then heated for 15 min. in a boiling-water bath. After the precipitate had been re-
moved by centrifugation at 14000 rpm for 15 min., the supernatant was then ultrafilt-
rated with membrane filter (M.W. Cutoff 2000; Amicon).
The filtrate was then applied to a 2.5 x 40 em column of Sephadex G-15 (prewashed
with water). The column was eluted with 200 ml of water. The eluate was collected in
4 ml fractions, while monitoring the absorbance at 280 nm for peptides and at 820 nm for
total phosphorus. Each fraction was collected, and determined the phosphonate
phosphours, amino acid and ACE inhibitory activity.
The molecular weight distribution of peptide was estimated by using adenine
dinucleotide (M.W. 830), Hippuryl-L-Histidyl-Leucine (M.W. 430) and L-tyrosine
(M.W.181).
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Quantitative analysis:
Total phosphorus was estimated by the method of Chen et.al 1171. Phosphonate-
phosphorus was estimated by the method of Tamari et.al 11B1 • Amino acid analyses were
carried out with a JTC-200A amino acid analyzer. The sample for amino acid analyses
was hydrolyzated in 6 M HCI at HOaC for 24 hrs. The nitrogen and protein were ana-
lyzed in the usual way (% protein = % N x 6.25).
Thin layer chromatography:
The presence of phosphopeptide in the T-l-l, T-1-2 and T-1-3 was demonstrated by
thin layer chromatography (Kiesel gel 60F254 , 20 x 20 em, thick 0.25 mm) using two dif-
ferent solvent systems.
RESULTS AND DISCUSSION
Fig 1 shows the Sephadex G-50 column chromatogram of the tryptic hydrolyzates
of Oyster, Crassostrea gigas. The experimental details were described in the text. The
entire effluent was collected in tubes on a fraction collector for quantitative analysis of
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Fig. 1 Chromatographic Profile of Phosphopeptides Eluted by
Sephadex G-50 Column Chromatography from the
Hydrolyzates Obtained by Tryptic Hydrolysis of Oyster,
Crassostrea gigas.
The experimental details are described in the text.
• -. indicate total-phosphorus and. -. indicate
phosphopeptides at 280 nm in the collected fractions. T-l
and T-2 represent combined fractions No.5~10 and frac-
tions No.15~26, respectively.
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Phosphorus-containing two peaks and two peaks of peptides at 280 nm were eluted
from the column in the case of tryptic hydrolyzates. The first peak and the second peak
designated as T-l and T-2, respectively. Fraction No.5~10 of the T-l, and fraction
No.15 ~ 26 of the T-2 were pooled, and analyzed for ACE inhibitory activity.
Table 1 . Angiotensin Converting Enzyme Inhibitory Activity of
the T-1 and T-2 Phosphopeptides Eluted by Sephadex
G-50 Column Chromatography of the Hydrolyzates











The inhibition of ACE of the T-l and T-2 was investigated in vitro. It has been dem-
onstrated that T-l and T-2 had similar inhibitory activity and showed 2.73 and 2.64 mg
protein/ml inhibition against ACE at ICon value (Table 1) .
Therefore, the T-l of ACE inhibitors were further purified by ultrafiltration and
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Fig.2 Chromatographic Profile of Phosphopeptides by Rechromatography on
Sephadex G-15 Column of Pepsin Digest of Active Fraction (T-1)
Obtained from Sephadex G-50 Chromatography.
The active fraction (T-l) obtained from Sephadex G-50 Chromatography
was applied on the Sephadex G-15 Column (2.5 x 40cm), pre-equilibrated
with water, and eluted with water. The eluate was collected in 4ml frac-
tions. • -. indicate total-phosphorus and. -. indicate phospho-
peptides at 280 nm in the collected fractions. T-1-1, T-1-2, and T-1-3
represent combined fractions No.13 ~ 17, fractions No.19 ~ 29, and frac-
tions No.35 ~ 43, respectively.
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Fig 2. shows the chromatographic profile of phosphopeptides by rechromatography
on Sephadex G-15 column of pepsin digest of the active fraction (T-l) obtained from
Sephadex G-50 column chromatography.
The experimental details were described in the text. The entire effluent was col-
lected in tubes on a fraction collector for quantitative analysis of the total-phosphorus
and for qualitative analysis of the phosphopeptides at 280 nm.
Phosphorus-containing three peaks and three peaks of peptides at 280 nm were
eluted from the column in the case of peptic hydrolyzates of T-l. The first peak, the sec-
ond peak and the third peak designated as T-1-1, T-1-2 and T-1-3, respectively.
The maximum total-phosphorus content was observed in fraction No.16 in the case
of T-1-1, and in fraction No.20 in the case of T-1-2, and in fraction No.38 in the case of
T-1-3 as shown in the Fig 2.
In addition, the maximum absorption at 280 nm was observed in fraction No.15 in
the case of T-1-1, and in fraction No.29 in the case of T-1-2 and in fraction No.38 in the
case of T-1-3. Fraction No.13~17 of the T-1-1, fraction No.19~29 of the T-1-2 and frac-
tion No.35~43 of the T-1-3 were pooled, and analyzed for phosphonate-phosphorus (C-
P), amino acids and ACE inhibitory activity.
Table 2. Phosphorus Contents of the T-1-1, T-1-2 and T-1-3 Fractionated
by Rechromatography on Sephadex G-15 Column of Peptic
Hydrolyzateds of T-1 Obtained from Sephadex G-50 Column
Chromatography.
Fraction T-P (f-lg/mD C-P (f-lg/ml) C-P/T-P (%)
T-1-1 0.84 0.279 33.25
T-1-2 5.72 0.172 3.01
T-1-3 1.36 0.370 27.12
Abbreviations used are:
C-P, Phosphonate-phosphorus; T-P, Total-phosphorus
Table 2 shows the phosphorus contents of the T-1-1, T-1-2 and T-1-3 eluted by
rechromatography on Sephadex G-15 column of peptic hydrolyzates of T-1.
The total-phosphorus content in the T-1-1, T-1-2 and T-1-3 fractions were 0.084,5.72
and 1.36 Jlg per ml of the peak, respectively.
The amounts of phosphonate-phosphorus (C-P) in the T-1-1, T-1-2 and T-1-3 were
0.279, 0.172 and 0.370 Jlg per ml of the peak.
In addition, about 33.25%,3.01 % and 27.12% of the total-phosphorus in the T-1-1,
T-1-2 and T-1-3 fractions was found to be phosphonate, which was primarily 2-
aminoethylphosphonic acid.
Table 3 summarized the amino acid compositions of the T-1-1, T-1-2 and T-1-3 frac-
tions. The amino acid compositions of the phosphopeptides fractions (T-1-1, T-1-2 and
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Table 3. Amino Acid Composition of Phosphopeptides in the T-1-1, T-1-2
and T-1-3 Fractionated by Rechromatography on Sephadex G-
15 Column of Peptic Hydrolyzates of the T-1 Obtained from
Sephadex G-50 Column Chromatography.
Amino Acid T-1-1 T-1-2 T-1-3
Asp 0.002 0.012 0.004
Thr 0.001 0.008 0.003
Ser 0.002 0.025 0.005
Glu 0.002 0.010 0.005
Gly 0.002 0.016 0.003
Ala 0.000 0.013 0.003
Cys 0.002 0.005 0.003
Val 0.000 0.008 0.005
Met 0.000 0.000 0.000
lIeu 0.000 0.004 0.003
Leu 0.002 0.007 0.009
Tyr 0.031 0.033 0.036
Phe 0.010 0.010 0.003
His 0.005 0.008 0.003
Lys 0.000 0.004 0.002
Arg 0.002 0.005 0.019
Pro 0.000 0.004 0.000
2-AEP 0.009 0.006 0.011
Total 0.070 0.177 0.115
. Values are expressed as mg/mg Nitrogen .
. Abbreviations used are: 2-AEP, 2-aminoethylphosphonic acid.
T-1-3) were characterized by relatively high percentage for Tyr, Ser, Arg, Ala, Asp, Glu
and Phe content, and the presence of unique amino acid, 2-aminoethylphosphonic acid,
(2-AEP) .
In T-1-3 phosphopeptide, the 2-AEP content was high, when compared to T-1-3,
other peaks (T-1-1 and T-1-2) had a low 2-AEP.
Cheung et.al'I9. and Matsui et.al'li. have reported that in was essential for strong
and competitive ACE inhibition that a peptide had aromatic amino acid residues at the
Table 4. Angiotensin I-Converting Enzyme Inhibitory Activity of the
T-1-1, T-1-2 and T-1-3 of Phosphopeptides Obtained by
Rechromatography on Sephadex G-15 Column of Peptic
Hydrolyzates of the T-1 Obtained from Sephadex G-50
Column Chromatography.
Fraction Inhibition (%) Protein (rug/ml)
IGiiJ
(mg protein/ml)
T-1-1 39.20 0.7780 0.159
T-1-2 65.34 0.7781 0.095
T-I-3 50.00 0.8750 0.140
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C-terminal (i.e., Try. Tyr. Pro.), and hydrophobic or basic ones at the N-terminal.
Table 4 shows angiotensin 1-converting enzyme inhibitory activity of the T-1-1, T-1-
2 and T-1-3 phosphopeptides eluted by Sephadex G-15 column chromatography and
ultrafiltration of the hydrolyzates obtained by pepsin hydrolysis of T-1.
The IC50 values for T-1-1, T-1-2 and T-1-3 were 0.159,0.095 and 0.140 mg protein/ml,
respectively .
The fraction T-1-2 had the most potent inhibitory activity and showed 0.095 mg pro-
tein/ml inhibition against ACE at IC50 value, and the IC50 value in the T-1-2 fraction was
1.67 and 1.47 times higher than those in the T-1-1 and in the T-1-3 fractions, respectively.
Fig.3~5 show the two dimensional thin layer chromatogram of the T-1-1, T-1-2 and
T-1-3 obtained by rechromatography on Sephadex G-15 column of peptic hydrolyzates of
the T-1 obtained from Sephadex G-50 column chromatography.
When the ACE inhibitory phosphopeptides were analyzed by thin layer chromatog-
raphy, some ninhydrine-positive spots were observed.





Fig.3 Two Dimensional Thin layer Chroma-
togram of the T-1-1 Obtained by
Rechromatography on Sephadex G-
15 Column of Peptic Hydrolyzate of
the T-1 Obtained from Sephadex G-50
Column Chromatography.
Solvents:
1 : n-butanol : acetone: acetic acid:
5% ammonium hydroxide: water
(4.5: 1.5: 1 : 1 : 2)
2: n-butanol : acetic acid: 5% am-
monium hydroxide (5.5 : 3 : 1.5)





Fig. 4 Two Dimensional Thin layer Chroma-
togram of the T-1-2 Obtained by
Rechromatography on Sephadex G-
15 Column of Peptic Hydrolyzate of
the T-1 Obtained from Sephadex G-50
Column Chromatography.
Solvents:
1 : n-butanol : acetone: acetic acid:
5% ammonium hydroxide: water
(4.5: 1.5: 1: 1 : 2)
2 : n-butanol : acetic acid: 5% am-
monium hydroxide (5.5: 3 : 1.5)
The spots were detected by 0.2%
ninhydrin in aceton.
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Fig. 5 Two Dimensional Thin layer Chroma-
togram of the T-I-3 Obtained by
Rechromatography on Sephadex G-
15 Column of Peptic Hydrolyzate of
the T-l Obtained from Sephadex G-50
Column Chromatography.
Solvents:
1 : n-butanol : acetone: acetic acid:
5% ammonium hydroxide: water
(4.5: 1.5: 1 : 1 : 2)
2 : n-butanol : acetic acid: 5% am-
monium hydroxide (5.5: 3 : 1.5)
The spots were detected by 0.2%
ninhydrin in aceton.
In addition, the results above, it has been demonstrated that the Sephadex G-15 gel
filtration patterns of the active fraction obtained from the Sephadex G-50 column chro-
matography indicated that the molecular weight of the phosphopeptides were about 200
~ 1000, and that the isolated peptide inhibitors occur as the phosphonate-containing
phosphonopeptides and phosphate-containing phosphopeptides, however more experi-
ments will be needed to prove the ACE inhibition of the phosphopeptides isolated from
oyster.
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